Related Experiment Videos
Bromocriptine in treatment of depression
1Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
DICP : the Annals of Pharmacotherapy
|July 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clozapine-associated extrapyramidal reaction.
The Annals of pharmacotherapy·2000
Atypical antipsychotic agents: a critical review.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Journal of child and adolescent psychopharmacology·1997
Antidepressant overdoses and resultant emergency department services: the impact of SSRIs.
Psychopharmacology bulletin·1997
Interactions between antipsychotic and antihypertensive drugs.
The Annals of pharmacotherapy·1995
Eradication of methicillin-resistant Staphylococcus aureus vaginitis with mupirocin.
DICP : the annals of pharmacotherapy·1991
Oral vancomycin-induced rash: case report and review of the literature.
DICP : the annals of pharmacotherapy·1991
Preventing medication prescribing errors.
DICP : the annals of pharmacotherapy·1991
Recommendations for establishing a drug and toxicology information center in a developing country.
DICP : the annals of pharmacotherapy·1991
Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review.
DICP : the annals of pharmacotherapy·1991
Early individualization of tricyclic antidepressant dosing using a Bayesian pharmacokinetic model.
DICP : the annals of pharmacotherapy·1991
RETRACTION: Up-regulated Mir-192-5p Expression Rescues Cognitive Impairment and Restores Neural Function in Mice With Depression via the Fbln2 -mediated TGF-β1 Signaling Pathway.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Therapeutic Advances and Biomarkers in Multiple Sclerosis.
Current neuropharmacology·2026